Aurora Biolabs

Pre-clinical

San Diego, United StatesFounded 2015aurorabiolabs.com

Aurora Biolabs operates as a premier manufacturer and service provider in the life sciences research tools sector, focusing on enabling drug discovery through reliable, ISO 17025-certified reagents and assays. As a subsidiary of Structure Based Design, Inc. (SBD), it leverages decades of scientific expertise to offer assay development, protein expression, and a 145K-compound library screening service. The company is strategically positioned as a direct US manufacturer, ensuring quality control and cost-effective solutions for academic, biotech, and pharmaceutical research clients.

Founded

2015

Focus

DiagnosticsProteomics

AI Company Overview

Technology Platform

Specializes in the production of high-purity recombinant drug target proteins and the development of precise, homogeneous TR-FRET (Time-Resolved Fluorescence Resonance Energy Transfer) fluorescence assays for high-throughput inhibitor screening and drug discovery optimization.

Opportunities

Significant growth opportunities exist in expanding its assay kit portfolio for next-generation oncology targets (e.g., additional KRAS mutants), leveraging its US manufacturing appeal for supply-chain-sensitive clients, and scaling its high-value contract services like the 145K-compound screening library and structural biology capabilities through its SBD affiliation.

Risk Factors

Key risks include intense competition from large, well-funded reagent conglomerates, dependence on the cyclical R&D spending of biopharma clients, potential technological disruption from new screening modalities, and operational challenges associated with scaling in-house manufacturing and retaining specialized scientific talent.

Competitive Landscape

Aurora Biolabs competes with large reagent suppliers (Thermo Fisher, Merck) and specialized assay providers (BPS Bioscience, Revvity). Its differentiation stems from deep expertise in challenging targets like KRAS, direct US-based manufacturing ensuring quality and supply chain control, and an integrated model combining products with high-end discovery services linked to structural biology expertise via its parent company SBD.